UBR2 Antibody

What is UBR2 and what are its key biological functions?

UBR2 (Ubiquitin Protein Ligase E3 Component N-Recognin 2) is a 1755 amino acid protein that functions as an E3 ubiquitin-protein ligase within the ubiquitin-proteasome system. It contains one UBR-type zinc finger and one RING-type zinc finger, which are crucial for its function in protein degradation pathways . UBR2 specifically recognizes and binds to proteins with destabilizing N-terminal residues, facilitating their ubiquitination and subsequent degradation .

Beyond its canonical role in the N-end rule pathway, UBR2 has several specialized functions:

• Transcriptional silencing during spermatogenesis, particularly in meiotic sex chromosome inactivation (MSCI)

• Regulation of T cell activation through interaction with DUSP22 and Lck

• Protein stabilization of specific binding partners like Tex19.1

Studies with UBR2-deficient mice have demonstrated its critical importance in reproductive biology, as these mice exhibit infertility due to defects in male meiosis .

How do I select the appropriate UBR2 antibody for my experimental needs?

When selecting a UBR2 antibody, consider these key factors:

• Species reactivity: Available UBR2 antibodies detect human and mouse UBR2, but cross-reactivity varies. The 8H10 monoclonal antibody specifically detects human UBR2 , while other antibodies like those used in mouse studies have different specificities .

• Application compatibility: Different antibodies are validated for different techniques:

  • Western blotting (WB): Most UBR2 antibodies work well for this application

  • Immunoprecipitation (IP): Specifically validated antibodies like 8H10 and PCRP-UBR2-1D12

  • Immunohistochemistry (IHC): PCRP-UBR2-1D12 is validated for IHC-P

  • Immunofluorescence (IF): Required for localization studies as shown in meiotic chromosome spreading

  • ELISA and flow cytometry: Limited antibodies are validated for these techniques

• Epitope location: For studying specific domains or interactions of UBR2, the epitope location matters. For example, the anti-Ubr2 antiserum generated against the N-terminal 100 amino acids was effective for detecting interactions with Tex19.1 .

• Validation evidence: Review the validation data for your specific application. For instance, the PCRP-UBR2-1D12 antibody is described as "proteome-validated monospecific" , while other antibodies have been validated through specific techniques like peptide competition assays .

How can I optimize immunoprecipitation protocols for studying UBR2 interactions?

Optimizing immunoprecipitation (IP) for UBR2 requires attention to several methodological details:

• Antibody selection: Use antibodies specifically validated for IP, such as mouse monoclonal antibody 8H10 or PCRP-UBR2-1D12 .

• Protein extraction conditions: UBR2 abundance can be low in total tissue extracts (as noted in testicular extract studies) . Consider:

  • Using enrichment steps prior to IP

  • Optimizing lysis buffers to preserve protein-protein interactions

  • Including protease and phosphatase inhibitors to prevent degradation

• IP procedure for low-abundance targets: When studying UBR2 in tissues like testes where its abundance is low:

  • Increase the amount of starting material

  • Perform sequential IPs (as demonstrated in the Tex19.1-UBR2 interaction studies)

  • Consider crosslinking approaches to stabilize transient interactions

• Verification methods: Confirm specificity through:

  • Reciprocal co-IPs (as demonstrated with Tex19.1)

  • Using tissue/cells from knockout models as negative controls

  • Peptide competition assays

• Detecting ubiquitination events: For studying UBR2-mediated ubiquitination or UBR2's own ubiquitination:

  • Use tandem IPs with denaturing conditions as demonstrated in DUSP22 studies

  • Include deubiquitinase inhibitors in lysis buffers

  • Consider using ubiquitin mutants to distinguish between different ubiquitin chain types (K48 vs K63)

What are the best approaches for visualizing UBR2 localization during meiosis?

Visualizing UBR2 localization during meiosis requires specialized techniques:

• Chromosome spreading: The preferred method for studying UBR2 localization on meiotic chromosomes involves:

  • Preparing spread chromosomes from testicular cells

  • Using fixation conditions that preserve chromosome structure

  • Applying immunofluorescence staining with anti-UBR2 antibodies

• Co-localization studies: To understand UBR2's relationship to meiotic processes:

  • Co-stain with markers of synapsis (SYCP3, SYCP1)

  • Include markers of unpaired axes and sex chromosomes

  • Use antibodies against ubiquitinated histones to correlate with UBR2 activity

• Temporal analysis: Track UBR2 localization through different stages of meiosis:

  • Leptotene: UBR2 appears as foci in chromatin and along axial elements

  • Zygotene: UBR2 enriches on unsynapsed axial regions

  • Pachytene: UBR2 accumulates on unpaired XY axes and throughout chromatin

• Validation controls:

  • Perform peptide competition assays to verify antibody specificity

  • Use UBR2-deficient tissues as negative controls

  • Compare with other known markers of meiotic silencing

What Western blotting protocol modifications are needed for reliable UBR2 detection?

UBR2 detection by Western blotting requires specific protocol optimizations:

• Protein extraction: UBR2 is often present at low levels, requiring:

  • Enrichment steps such as nuclear extraction for chromatin-associated UBR2

  • Higher protein loading amounts (50-100 μg)

  • Protection from degradation with fresh protease inhibitors

• Gel electrophoresis considerations:

  • UBR2 is a large protein (1755 amino acids), requiring low percentage gels (6-8%)

  • Longer running times to achieve good separation

  • Use of gradient gels can improve resolution

• Transfer conditions:

  • Extended transfer times or semi-dry transfer systems for large proteins

  • Lower methanol concentrations in transfer buffer

  • Consider using PVDF rather than nitrocellulose for better protein retention

• Antibody incubation:

  • Recommended dilutions: 1:500 for anti-UBR2 antisera

  • Extended incubation times (overnight at 4°C)

  • Enhanced blocking (5% BSA rather than milk for phosphorylated UBR2 detection)

• Detection optimization:

  • Use enhanced chemiluminescence systems for low-abundance detection

  • Consider signal amplification methods for tissues with low UBR2 expression

  • Image using extended exposure times if necessary

How can I design experiments to distinguish between UBR2's N-end rule and non-N-end rule functions?

Designing experiments to differentiate UBR2's canonical N-end rule functions from its other roles requires careful experimental approaches:

• Mutational analysis:

  • Create and express UBR2 mutants lacking specific domains (UBR-type zinc finger vs. RING-type zinc finger)

  • Generate substrate proteins with modified N-terminal residues to test N-end rule dependency

  • Use the Tex19.1 C2G and C2V mutants as models, which showed binding to UBR2 independent of the N-terminal cysteine

• Binding assays:

  • Compare binding patterns of known N-end rule substrates versus non-N-end rule partners

  • Use co-immunoprecipitation followed by mass spectrometry to identify binding regions

  • Perform domain mapping through truncation mutants

• Functional comparisons:

  • Design rescue experiments in UBR2-deficient cells with:

    • Wild-type UBR2

    • UBR2 with mutations in N-end rule recognition domains

    • UBR2 with mutations in other functional domains

  • Measure different endpoints (protein stabilization vs. degradation)

• Temporal regulation studies:

  • Investigate conditional knockout models to determine when different UBR2 functions are critical

  • Use synchronized cell populations to identify cell-cycle dependent roles

• Substrate fate analysis:

  • For N-end rule function: measure degradation rates of known substrates

  • For stabilization function: assess protein levels of binding partners like Tex19.1

  • For transcriptional silencing: perform chromatin immunoprecipitation and RNA-seq analyses

What approaches can be used to study UBR2's role in transcriptional silencing during spermatogenesis?

Studying UBR2's role in transcriptional silencing during spermatogenesis requires specialized approaches:

• Transcriptome analysis:

  • Perform RNA-seq or microarray analysis comparing wild-type and UBR2-deficient testes at specific developmental stages

  • Focus on genes known to be subject to meiotic sex chromosome inactivation (MSCI)

  • Organize data by chromosomal location to identify chromosome-wide effects

• Chromatin studies:

  • Perform ChIP-seq for UBR2 and markers of transcriptional silencing (H2AK119ub, H3K9me3)

  • Analyze histone modification patterns in the presence and absence of UBR2

  • Correlate UBR2 localization with transcriptional activity

• Cytological approaches:

  • Use chromosome spreading coupled with immunofluorescence to visualize:

    • UBR2 localization on meiotic chromosomes

    • Co-localization with markers of unsynapsed chromosomes

    • Relationship to the XY body formation

• Single-cell analysis:

  • Apply single-cell RNA-seq to capture heterogeneity in spermatogenic defects

  • Correlate transcriptional profiles with stages of meiotic progression

  • Compare with bulk RNA-seq data to identify subpopulation-specific effects

• Experimental data table from UBR2-deficient mice:

Data derived from microarray analysis of ~22,000 probe sets in P17 testes .

How can I investigate the phosphorylation-dependent regulation of UBR2 in T-cell signaling?

Investigating the phosphorylation-dependent regulation of UBR2 in T-cell signaling requires:

• Phosphorylation site mapping:

  • Perform mass spectrometry analysis of UBR2 isolated from resting vs. activated T cells

  • Create phospho-specific antibodies against identified sites

  • Generate phosphomimetic (S→D) and phospho-deficient (S→A) mutants of key residues

• Functional interaction studies with DUSP22:

  • Use co-immunoprecipitation with wild-type vs. catalytically inactive DUSP22 (C88S)

  • Perform in vitro dephosphorylation assays with purified components

  • Use phosphatase inhibitors to block DUSP22 activity in cells

• Ubiquitination analysis:

  • Examine K48-linked ubiquitination of UBR2 in the presence/absence of DUSP22

  • Test the ubiquitination status of UBR2 K94/779/1599R mutants

  • Use ubiquitin mutants to distinguish between different ubiquitin linkage types

• T-cell signaling and activation studies:

  • Measure TCR signaling outputs in cells expressing:

    • Wild-type UBR2

    • Phosphorylation site mutants

    • Ubiquitination site mutants (K94/779/1599R)

  • Assess downstream effects on Lck Tyr394 phosphorylation

  • Measure cytokine production as a functional readout

• Single-cell analysis approaches:

  • Apply phospho-flow cytometry to measure UBR2 phosphorylation during T-cell activation

  • Use single-cell RNA-seq to correlate UBR2 activity with gene expression profiles

  • Employ live-cell imaging to track the dynamics of UBR2 localization during T-cell activation

How can I address issues with UBR2 antibody specificity and cross-reactivity?

When facing UBR2 antibody specificity issues, consider these methodological solutions:

• Validation approaches:

  • Perform peptide competition assays as demonstrated in the meiotic chromosome studies

  • Use tissues/cells from UBR2 knockout models as negative controls

  • Compare results from multiple different UBR2 antibodies targeting different epitopes

• Pre-absorption techniques:

  • Pre-absorb the antibody with the immunizing peptide

  • Use purified recombinant UBR2 fragments to test specificity

  • Consider cross-absorption with related UBR family proteins (UBR1, UBR4, UBR5)

• Alternative detection strategies:

  • Use epitope-tagging approaches (FLAG, HA, GFP) for exogenously expressed UBR2

  • Consider proximity labeling methods (BioID, APEX) to identify interacting proteins

  • Implement CRISPR-based endogenous tagging where possible

• Protocol modifications:

  • Optimize blocking conditions (BSA vs. milk, concentration, time)

  • Test different antibody dilutions and incubation conditions

  • Consider using monovalent antibody fragments (Fab) to reduce non-specific binding

• Quantitative validation:

  • Perform quantitative analysis of band intensity in wild-type vs. knockout samples

  • Use recombinant UBR2 protein standards for calibration

  • Document the specific validation procedures in your experimental reports

What strategies can address the challenge of detecting low-abundance UBR2 in tissue samples?

Detecting low-abundance UBR2 in tissue samples requires specialized techniques:

• Sample enrichment approaches:

  • Perform subcellular fractionation to isolate nuclear/chromatin fractions

  • Use immunoprecipitation to concentrate UBR2 before detection

  • Consider tissue-specific extraction protocols (e.g., specialized methods for testicular tissue)

• Signal amplification methods:

  • Use tyramide signal amplification for immunohistochemistry and immunofluorescence

  • Apply more sensitive detection systems for Western blotting

  • Consider using nano-immunoassay platforms or microfluidic immunoassays

• Increase starting material:

  • Scale up tissue amount for protein extraction

  • Pool samples from multiple animals for preliminary studies

  • Use cell populations enriched for UBR2 expression

• Alternative detection methods:

  • Consider targeted mass spectrometry approaches (PRM, MRM)

  • Use proximity ligation assay (PLA) to detect specific protein interactions

  • Employ digital protein expression measurement systems

• Optimize antibody conditions:

  • Extend primary antibody incubation time (overnight at 4°C)

  • Test higher antibody concentrations

  • Use antibody enhancer solutions

How should I interpret contradictory findings between UBR2 functions in different cell types or experimental systems?

When facing contradictory findings about UBR2 functions, consider these analytical approaches:

• Cell type-specific context analysis:

  • Compare UBR2 expression levels across different cell types

  • Identify cell-specific binding partners through differential interactome analysis

  • Examine cell type-specific post-translational modifications

• Reconciling different functional roles:

  • UBR2 demonstrates both degradative (N-end rule) and stabilizing (Tex19.1) functions

  • Consider that these functions may:

    • Operate in different cellular compartments

    • Be regulated by different post-translational modifications

    • Depend on specific binding partners

• Developmental timing considerations:

  • The role of UBR2 in spermatogenesis is stage-specific

  • Analyze temporal expression patterns in different systems

  • Consider conditional knockout models to dissect time-dependent functions

• Technical differences evaluation:

  • Analyze differences in experimental approaches (in vitro vs. in vivo)

  • Consider antibody specificity issues across different studies

  • Evaluate genetic background effects in animal models

• Integrated data analysis:

  • Use systems biology approaches to integrate transcriptomic, proteomic, and functional data

  • Develop computational models to predict context-dependent functions

  • Perform meta-analysis of published studies to identify consistent findings

What are the best approaches for correlating UBR2 function with phenotypic outcomes in knockout models?

To effectively correlate UBR2 function with phenotypic outcomes in knockout models:

• Comprehensive phenotypic characterization:

  • Perform histological analysis of affected tissues (particularly testes)

  • Conduct fertility studies to quantify reproductive defects

  • Examine embryonic development with particular attention to sex-specific effects

• Molecular phenotyping approaches:

  • Perform transcriptome analysis of affected tissues (RNA-seq, microarray)

  • Analyze the proteome to identify stabilized or destabilized proteins

  • Conduct epigenomic profiling to assess changes in chromatin organization

• Mechanistic correlation studies:

  • Analyze specific substrates or partners (e.g., Tex19.1 protein levels)

  • Examine meiotic chromosome synapsis through cytological approaches

  • Measure transcriptional silencing of sex-linked genes

• Genetic interaction analyses:

  • Generate compound mutants (e.g., UBR2 with Tex19.1)

  • Perform genetic rescue experiments with wild-type and mutant UBR2

  • Create tissue-specific conditional knockouts to isolate function

• Phenotypic rescue strategies:

  • Design complementation studies with:

    • Wild-type UBR2

    • Domain-specific mutants

    • Phosphorylation site mutants

  • Analyze which molecular functions correlate with specific phenotypic rescue